Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 285

1.

Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial.

Carrie C, Magné N, Burban-Provost P, Sargos P, Latorzeff I, Lagrange JL, Supiot S, Belkacemi Y, Peiffert D, Allouache N, Dubray BM, Servagi-Vernat S, Suchaud JP, Crehange G, Guerif S, Brihoum M, Barbier N, Graff-Cailleaud P, Ruffion A, Dussart S, Ferlay C, Chabaud S.

Lancet Oncol. 2019 Oct 16. pii: S1470-2045(19)30486-3. doi: 10.1016/S1470-2045(19)30486-3. [Epub ahead of print]

PMID:
31629656
2.

T Cell-Derived IL-17A Induces Vascular Dysfunction via Perivascular Fibrosis Formation and Dysregulation of ·NO/cGMP Signaling.

Schüler R, Efentakis P, Wild J, Lagrange J, Garlapati V, Molitor M, Kossmann S, Oelze M, Stamm P, Li H, Schäfer K, Münzel T, Daiber A, Waisman A, Wenzel P, Karbach SH.

Oxid Med Cell Longev. 2019 Jul 18;2019:6721531. doi: 10.1155/2019/6721531. eCollection 2019.

3.

RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort study.

Mirjolet C, Merlin JL, Truc G, Noël G, Thariat J, Domont J, Sargos P, Renard-Oldrini S, Ray-Coquard I, Liem X, Chevreau C, Lagrange JL, Mahé MA, Collin F, Bonnetain F, Bertaut A, Maingon P.

EBioMedicine. 2019 Mar;41:420-426. doi: 10.1016/j.ebiom.2019.02.031. Epub 2019 Mar 1.

4.

Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical Trial.

Oudard S, Latorzeff I, Caty A, Miglianico L, Sevin E, Hardy-Bessard AC, Delva R, Rolland F, Mouret L, Priou F, Beuzeboc P, Gravis G, Linassier C, Gomez P, Voog E, Muracciole X, Abraham C, Banu E, Ferrero JM, Ravaud A, Krakowski I, Lagrange JL, Deplanque G, Zylberait D, Bozec L, Houede N, Culine S, Elaidi R.

JAMA Oncol. 2019 May 1;5(5):623-632. doi: 10.1001/jamaoncol.2018.6607.

PMID:
30703190
5.

Endothelial α1AMPK modulates angiotensin II-mediated vascular inflammation and dysfunction.

Kröller-Schön S, Jansen T, Tran TLP, Kvandová M, Kalinovic S, Oelze M, Keaney JF Jr, Foretz M, Viollet B, Daiber A, Kossmann S, Lagrange J, Frenis K, Wenzel P, Münzel T, Schulz E.

Basic Res Cardiol. 2019 Jan 14;114(2):8. doi: 10.1007/s00395-019-0717-2.

PMID:
30643968
6.

Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07).

Vaugier L, Palpacuer C, Rio E, Goineau A, Pasquier D, Buthaud X, De Laroche G, Beckendorf V, Sargos P, Créhange G, Pommier P, Loos G, Hasbini A, Latorzeff I, Silva M, Denis F, Lagrange JL, Campion L, Supiot S.

Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1061-1067. doi: 10.1016/j.ijrobp.2018.12.020. Epub 2018 Dec 14.

7.

Thromboinflammation and Vascular Dysfunction.

Karbach S, Lagrange J, Wenzel P.

Hamostaseologie. 2019 Jun;39(2):180-187. doi: 10.1055/s-0038-1676130. Epub 2018 Dec 4.

PMID:
30513535
8.

The regulatory role of coagulation factors in vascular function.

Lagrange J, Wenzel P.

Front Biosci (Landmark Ed). 2019 Jan 1;24:494-513. Review.

PMID:
30468669
9.

Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial.

de Crevoisier R, Bayar MA, Pommier P, Muracciole X, Pêne F, Dudouet P, Latorzeff I, Beckendorf V, Bachaud JM, Laplanche A, Supiot S, Chauvet B, Nguyen TD, Bossi A, Créhange G, Lagrange JL.

Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1420-1429. doi: 10.1016/j.ijrobp.2018.07.2006. Epub 2018 Jul 31.

PMID:
30071296
10.

α1AMPK deletion in myelomonocytic cells induces a pro-inflammatory phenotype and enhances angiotensin II-induced vascular dysfunction.

Jansen T, Kröller-Schön S, Schönfelder T, Foretz M, Viollet B, Daiber A, Oelze M, Brandt M, Steven S, Kvandová M, Kalinovic S, Lagrange J, Keaney JF Jr, Münzel T, Wenzel P, Schulz E.

Cardiovasc Res. 2018 Dec 1;114(14):1883-1893. doi: 10.1093/cvr/cvy172.

PMID:
29982418
11.

Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug group.

Meyer E, Pasquier D, Bernadou G, Calais G, Maroun P, Bossi A, Theodore C, Albiges L, Stefan D, de Crevoisier R, Hennequin C, Lagrange JL, Grellard JM, Clarisse B, Licaj I, Habrand JL, Carrie C, Joly F.

Eur J Cancer. 2018 Jul;98:38-47. doi: 10.1016/j.ejca.2018.04.008. Epub 2018 Jun 1.

PMID:
29864737
12.

Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial.

Bourgier C, Castan F, Riou O, Nguyen TD, Peignaux K, Lemanski C, Lagrange JL, Kirova Y, Lartigau E, Belkacemi Y, Rivera S, Noël G, Clippe S, Mornex F, Hennequin C, Gourgou S, Brengues M, Fenoglietto P, Ozsahin EM, Azria D.

Oncotarget. 2018 Mar 2;9(21):15757-15765. doi: 10.18632/oncotarget.24606. eCollection 2018 Mar 20.

13.

Visualizing Leukocyte Rolling and Adhesion in Angiotensin II-Infused Mice: Techniques and Pitfalls.

Lagrange J, Kossmann S, Kiouptsi K, Wenzel P.

J Vis Exp. 2018 Jan 4;(131). doi: 10.3791/56948.

14.

Implication of Free Fatty Acids in Thrombin Generation and Fibrinolysis in Vascular Inflammation in Zucker Rats and Evolution with Aging.

Lagrange J, Didelot M, Mohamadi A, Walton LA, Bloemen S, de Laat B, Louis H, Thornton SN, Derby B, Sherratt MJ, Fève B, Challande P, Akhtar R, Cruickshank JK, Lacolley P, Regnault V.

Front Physiol. 2017 Nov 22;8:949. doi: 10.3389/fphys.2017.00949. eCollection 2017.

15.

Platelet aggregation impacts thrombin generation assessed by calibrated automated thrombography.

Didelot M, Docq C, Wahl D, Lacolley P, Regnault V, Lagrange J.

Platelets. 2018 Mar;29(2):156-161. doi: 10.1080/09537104.2017.1356452. Epub 2017 Oct 12.

PMID:
29022492
16.

Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension.

Kossmann S, Lagrange J, Jäckel S, Jurk K, Ehlken M, Schönfelder T, Weihert Y, Knorr M, Brandt M, Xia N, Li H, Daiber A, Oelze M, Reinhardt C, Lackner K, Gruber A, Monia B, Karbach SH, Walter U, Ruggeri ZM, Renné T, Ruf W, Münzel T, Wenzel P.

Sci Transl Med. 2017 Feb 1;9(375). pii: eaah4923. doi: 10.1126/scitranslmed.aah4923.

PMID:
28148841
17.

Performance of Four Frailty Classifications in Older Patients With Cancer: Prospective Elderly Cancer Patients Cohort Study.

Ferrat E, Paillaud E, Caillet P, Laurent M, Tournigand C, Lagrange JL, Droz JP, Balducci L, Audureau E, Canouï-Poitrine F, Bastuji-Garin S.

J Clin Oncol. 2017 Mar;35(7):766-777. doi: 10.1200/JCO.2016.69.3143. Epub 2017 Jan 17.

18.

Assessment of Vascular Dysfunction and Inflammation Induced by Angiotensin II in Mice.

Lagrange J, Kossmann S, Wenzel P.

Methods Mol Biol. 2017;1559:439-453. doi: 10.1007/978-1-4939-6786-5_30.

PMID:
28063062
19.

Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Update of the Long-Term Survival Results of the GETUG-01 Randomized Study.

Pommier P, Chabaud S, Lagrange JL, Richaud P, Le Prise E, Wagner JP, Azria D, Beckendorf V, Suchaud JP, Bernier V, Perol D, Carrie C.

Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):759-769. doi: 10.1016/j.ijrobp.2016.06.2455.

PMID:
27788949
20.

Gut Microbiota Promote Angiotensin II-Induced Arterial Hypertension and Vascular Dysfunction.

Karbach SH, Schönfelder T, Brandão I, Wilms E, Hörmann N, Jäckel S, Schüler R, Finger S, Knorr M, Lagrange J, Brandt M, Waisman A, Kossmann S, Schäfer K, Münzel T, Reinhardt C, Wenzel P.

J Am Heart Assoc. 2016 Aug 30;5(9). pii: e003698. doi: 10.1161/JAHA.116.003698.

21.

[Radiotherapy of bone metastases].

Thureau S, Vieillard MH, Supiot S, Lagrange JL.

Cancer Radiother. 2016 Sep;20 Suppl:S227-34. doi: 10.1016/j.canrad.2016.07.027. Epub 2016 Aug 11. French.

PMID:
27523421
22.

[Radiotherapy of bladder cancer].

Riou O, Chauvet B, Lagrange JL, Martin P, Llacer Moscardo C, Charissoux M, Lauche O, Aillères N, Fenoglietto P, Azria D.

Cancer Radiother. 2016 Sep;20 Suppl:S196-9. doi: 10.1016/j.canrad.2016.07.010. Epub 2016 Aug 9. French.

PMID:
27521030
23.

What Do Older Adults Know About Their Cancer Diagnosis and Treatment? The ELCAPA-08 Cohort Study.

Kempf E, Caillet P, Rousseau B, Le Thuaut A, Bastuji-Garin S, Liuu E, Lagrange JL, Tournigand C, Paillaud E, Canouï-Poitrine F.

J Am Geriatr Soc. 2016 Jun;64(6):1360-2. doi: 10.1111/jgs.14154. No abstract available.

PMID:
27321623
24.

Identification of a rectal subregion highly predictive of rectal bleeding in prostate cancer IMRT.

Dréan G, Acosta O, Ospina JD, Fargeas A, Lafond C, Corrégé G, Lagrange JL, Créhange G, Simon A, Haigron P, de Crevoisier R.

Radiother Oncol. 2016 Jun;119(3):388-97. doi: 10.1016/j.radonc.2016.04.023. Epub 2016 May 9.

PMID:
27173457
25.

Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial.

Carrie C, Hasbini A, de Laroche G, Richaud P, Guerif S, Latorzeff I, Supiot S, Bosset M, Lagrange JL, Beckendorf V, Lesaunier F, Dubray B, Wagner JP, N'Guyen TD, Suchaud JP, Créhange G, Barbier N, Habibian M, Ferlay C, Fourneret P, Ruffion A, Dussart S.

Lancet Oncol. 2016 Jun;17(6):747-756. doi: 10.1016/S1470-2045(16)00111-X. Epub 2016 May 6. Erratum in: Lancet Oncol. 2016 Jun;17 (6):e223. Erratum in: Lancet Oncol. 2019 Jun;20(6):e293.

PMID:
27160475
26.

[Repeated radiation dose effect and DNA repair: Importance of the individual factor and the time interval between the doses].

Viau M, Perez AF, Bodgi L, Devic C, Granzotto A, Ferlazzo ML, Bourguignon M, Puisieux A, Lacornerie T, Lartigau É, Lagrange JL, Foray N.

Cancer Radiother. 2016 May;20(3):217-25. doi: 10.1016/j.canrad.2015.05.035. Epub 2016 Mar 22. Review. French.

PMID:
27020715
27.

Four Distinct Health Profiles in Older Patients With Cancer: Latent Class Analysis of the Prospective ELCAPA Cohort.

Ferrat E, Audureau E, Paillaud E, Liuu E, Tournigand C, Lagrange JL, Canoui-Poitrine F, Caillet P, Bastuji-Garin S; ELCAPA Study Group.

J Gerontol A Biol Sci Med Sci. 2016 Dec;71(12):1653-1660. Epub 2016 Mar 22.

28.

Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity.

COPERNIC project investigators, Granzotto A, Benadjaoud MA, Vogin G, Devic C, Ferlazzo ML, Bodgi L, Pereira S, Sonzogni L, Forcheron F, Viau M, Etaix A, Malek K, Mengue-Bindjeme L, Escoffier C, Rouvet I, Zabot MT, Joubert A, Vincent A, Dalla Venezia N, Bourguignon M, Canat EP, d'Hombres A, Thébaud E, Orbach D, Stoppa-Lyonnet D, Radji A, Doré E, Pointreau Y, Bourgier C, Leblond P, Defachelles AS, Lervat C, Guey S, Feuvret L, Gilsoul F, Berger C, Moncharmont C, de Laroche G, Moreau-Claeys MV, Chavaudra N, Combemale P, Biston MC, Malet C, Martel-Lafay I, Laude C, Hau-Desbat NH, Ziouéche A, Tanguy R, Sunyach MP, Racadot S, Pommier P, Claude L, Baleydier F, Fleury B, de Crevoisier R, Simon JM, Verrelle P, Peiffert D, Belkacemi Y, Bourhis J, Lartigau E, Carrie C, De Vathaire F, Eschwege F, Puisieux A, Lagrange JL, Balosso J, Foray N.

Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):450-60. doi: 10.1016/j.ijrobp.2015.11.013. Epub 2015 Nov 14.

PMID:
26867874
29.

Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial.

Azria D, Riou O, Castan F, Nguyen TD, Peignaux K, Lemanski C, Lagrange JL, Kirova Y, Lartigau E, Belkacemi Y, Bourgier C, Rivera S, Noël G, Clippe S, Mornex F, Hennequin C, Kramar A, Gourgou S, Pèlegrin A, Fenoglietto P, Ozsahin EM.

EBioMedicine. 2015 Oct 25;2(12):1965-73. doi: 10.1016/j.ebiom.2015.10.024. eCollection 2015 Dec.

30.

Heme oxygenase-1 suppresses a pro-inflammatory phenotype in monocytes and determines endothelial function and arterial hypertension in mice and humans.

Wenzel P, Rossmann H, Müller C, Kossmann S, Oelze M, Schulz A, Arnold N, Simsek C, Lagrange J, Klemz R, Schönfelder T, Brandt M, Karbach SH, Knorr M, Finger S, Neukirch C, Häuser F, Beutel ME, Kröller-Schön S, Schulz E, Schnabel RB, Lackner K, Wild PS, Zeller T, Daiber A, Blankenberg S, Münzel T.

Eur Heart J. 2015 Dec 21;36(48):3437-46. doi: 10.1093/eurheartj/ehv544. Epub 2015 Oct 29. Erratum in: Eur Heart J. 2016 Feb 21;:.

PMID:
26516175
31.

Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU).

Sargos P, Guerif S, Latorzeff I, Hennequin C, Pommier P, Lagrange JL, Créhange G, Chapet O, de Crevoisier R, Azria D, Supiot S, Habibian M, Soulié M, Richaud P.

Cancer Treat Rev. 2015 Dec;41(10):814-20. doi: 10.1016/j.ctrv.2015.10.005. Epub 2015 Oct 23. Review.

PMID:
26508669
32.

[Symptomatic extramedullary haematopoiesis in β-thalassemia: A retrospective single centre study].

Maazoun F, Gellen Dautremer J, Boutekadjirt A, Pissard S, Habibi A, Bachir D, Rahmouni A, Bartolucci P, Debbache K, Lagrange JL, Michel M, Galacteros F.

Rev Med Interne. 2016 Jan;37(1):5-12. doi: 10.1016/j.revmed.2015.07.005. Epub 2015 Sep 26. French.

PMID:
26410419
33.

[Radiotherapy of bone metastases: Which fractionations?].

Thureau S, Leysalle A, Faivre JC, Lagrange JL.

Cancer Radiother. 2015 Oct;19(6-7):437-41. doi: 10.1016/j.canrad.2015.06.015. Epub 2015 Aug 28. French.

PMID:
26321686
34.

Geriatric assessment findings independently associated with clinical depression in 1092 older patients with cancer: the ELCAPA Cohort Study.

Canoui-Poitrine F, Reinald N, Laurent M, Guery E, Caillet P, David JP, Tournigand C, Lagrange JL, Bastuji-Garin S, Lemogne C, Paillaud E; ELCAPA Study Group.

Psychooncology. 2016 Jan;25(1):104-11. doi: 10.1002/pon.3886. Epub 2015 Jun 30.

PMID:
26123351
35.

Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial.

Fizazi K, Faivre L, Lesaunier F, Delva R, Gravis G, Rolland F, Priou F, Ferrero JM, Houede N, Mourey L, Theodore C, Krakowski I, Berdah JF, Baciuchka M, Laguerre B, Fléchon A, Ravaud A, Cojean-Zelek I, Oudard S, Labourey JL, Chinet-Charrot P, Legouffe E, Lagrange JL, Linassier C, Deplanque G, Beuzeboc P, Davin JL, Martin AL, Habibian M, Laplanche A, Culine S.

Lancet Oncol. 2015 Jul;16(7):787-94. doi: 10.1016/S1470-2045(15)00011-X. Epub 2015 May 28.

PMID:
26028518
36.

Predictors of 1-Year Mortality in a Prospective Cohort of Elderly Patients With Cancer.

Ferrat E, Paillaud E, Laurent M, Le Thuaut A, Caillet P, Tournigand C, Lagrange JL, Canouï-Poitrine F, Bastuji-Garin S; ELPACA Study Group.

J Gerontol A Biol Sci Med Sci. 2015 Sep;70(9):1148-55. doi: 10.1093/gerona/glv025. Epub 2015 Apr 1.

PMID:
25834194
37.

Vascular smooth muscle cells are responsible for a prothrombotic phenotype of spontaneously hypertensive rat arteries.

Ait Aissa K, Lagrange J, Mohamadi A, Louis H, Houppert B, Challande P, Wahl D, Lacolley P, Regnault V.

Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):930-7. doi: 10.1161/ATVBAHA.115.305377. Epub 2015 Feb 26.

PMID:
25722431
38.

[Intraprostatic calcifications as natural fiducial markers in image-guided radiotherapy for prostate cancer].

Sbai A, Thariat J, Tachfouti N, Pan Q, Lagrange JL.

Cancer Radiother. 2014 Dec;18(8):740-4. doi: 10.1016/j.canrad.2014.07.161. Epub 2014 Oct 19. French.

PMID:
25451671
39.

Optimal management of elderly cancer patients: usefulness of the Comprehensive Geriatric Assessment.

Caillet P, Laurent M, Bastuji-Garin S, Liuu E, Culine S, Lagrange JL, Canoui-Poitrine F, Paillaud E.

Clin Interv Aging. 2014 Sep 29;9:1645-60. doi: 10.2147/CIA.S57849. eCollection 2014. Review.

40.

[Prostate cancer: what treatment techniques for which tumors? Ethical and methodological issues].

de Crevoisier R, Castelli J, Guérif S, Pommier P, Créhange G, Chauvet B, Lagrange JL.

Cancer Radiother. 2014 Oct;18(5-6):369-78. doi: 10.1016/j.canrad.2014.07.154. Epub 2014 Sep 6. Review. French.

PMID:
25199865
41.

[Postoperative radiotherapy of prostate cancer].

Guérif S, Latorzeff I, Lagrange JL, Hennequin C, Supiot S, Garcia A, François P, Soulié M, Richaud P, Salomon L.

Cancer Radiother. 2014 Oct;18(5-6):517-23. doi: 10.1016/j.canrad.2014.07.149. Epub 2014 Sep 5. Review. French.

PMID:
25195116
42.

Random forests to predict rectal toxicity following prostate cancer radiation therapy.

Ospina JD, Zhu J, Chira C, Bossi A, Delobel JB, Beckendorf V, Dubray B, Lagrange JL, Correa JC, Simon A, Acosta O, de Crevoisier R.

Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1024-1031. doi: 10.1016/j.ijrobp.2014.04.027. Epub 2014 Jul 8.

PMID:
25035205
43.

Adjuvant radiotherapy for extremity and trunk wall atypical lipomatous tumor/well-differentiated LPS (ALT/WD-LPS): a French Sarcoma Group (GSF-GETO) study.

Cassier PA, Kantor G, Bonvalot S, Lavergne E, Stoeckle E, Le Péchoux C, Meeus P, Sunyach MP, Vaz G, Coindre JM, Linassier C, Labib A, Delcambre C, Bay JO, Leyvraz S, Dubergé T, Lagrange JL, Duret A, Blay JY.

Ann Oncol. 2014 Sep;25(9):1854-60. doi: 10.1093/annonc/mdu202. Epub 2014 Jun 8.

PMID:
24914041
44.

Skeletal muscle perilipin 3 and coatomer proteins are increased following exercise and are associated with fat oxidation.

Covington JD, Galgani JE, Moro C, LaGrange JM, Zhang Z, Rustan AC, Ravussin E, Bajpeyi S.

PLoS One. 2014 Mar 14;9(3):e91675. doi: 10.1371/journal.pone.0091675. eCollection 2014.

45.

Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task force.

Kunkler IH, Audisio R, Belkacemi Y, Betz M, Gore E, Hoffe S, Kirova Y, Koper P, Lagrange JL, Markouizou A, Pfeffer R, Villa S; SIOG Radiotherapy Task Force.

Ann Oncol. 2014 Nov;25(11):2134-46. doi: 10.1093/annonc/mdu104. Epub 2014 Mar 13. Review.

PMID:
24625455
46.

Assessment of solid cancer treatment feasibility in older patients: a prospective cohort study.

Laurent M, Paillaud E, Tournigand C, Caillet P, Le Thuaut A, Lagrange JL, Beauchet O, Vincent H, Carvahlo-Verlinde M, Culine S, Bastuji-Garin S, Canouï-Poitrine F; ELCAPA Study Group.

Oncologist. 2014 Mar;19(3):275-82. doi: 10.1634/theoncologist.2013-0351. Epub 2014 Feb 25.

47.

Endothelial mineralocorticoid receptor activation enhances endothelial protein C receptor and decreases vascular thrombosis in mice.

Lagrange J, Li Z, Fassot C, Bourhim M, Louis H, Nguyen Dinh Cat A, Parlakian A, Wahl D, Lacolley P, Jaisser F, Regnault V.

FASEB J. 2014 May;28(5):2062-72. doi: 10.1096/fj.13-238188. Epub 2014 Jan 22.

PMID:
24451386
48.

[Advances in radiation oncology for metastatic bone disease].

Thariat J, Fric D, Kerr C, Leysalle A, Angellier G, Dejean C, Tuillier T, Bensadoun RJ, Lagrange JL.

Bull Cancer. 2013 Nov;100(11):1187-97. doi: 10.1684/bdc.2013.1849. Review. French.

PMID:
24172705
49.

[Radiotherapy of bone metastases].

Leysalle A, Fric D, Lagrange JL, Thariat J.

Bull Cancer. 2013 Nov;100(11):1175-85. doi: 10.1684/bdc.2013.1845. Review. French.

PMID:
24158700
50.

Opposite predictive value of pulse pressure and aortic pulse wave velocity on heart failure with reduced left ventricular ejection fraction: insights from an Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) substudy.

Regnault V, Lagrange J, Pizard A, Safar ME, Fay R, Pitt B, Challande P, Rossignol P, Zannad F, Lacolley P.

Hypertension. 2014 Jan;63(1):105-11. doi: 10.1161/HYPERTENSIONAHA.113.02046. Epub 2013 Oct 14.

PMID:
24126172

Supplemental Content

Loading ...
Support Center